Your Source for Venture Capital and Private Equity Financings

VC-funded Company:

Vividion Therapeutics
5820 Nancy Ridge Drive
San Diego, CA 92121
Phone: 858-345-4690
www.vividion.com

Vividion Therapeutics is a biotechnology company focused on developing innovative therapeutics that treat major unmet medical needs using the first platform for proteome-wide small molecule drug discovery. The company's cutting-edge platform is based on seminal work from the labs of Professors Benjamin Cravatt, Phil Baran, and Jin-Quan Yu at The Scripps Research Institute in La Jolla, CA. Vividion previously raised a $45 Million Series A from ARCH Venture Partners, Versant Ventures, and Cardinal Partners. In March 2018, the Company established a multi-year, $101 Million up-front strategic collaboration with Celgene Corporation, aimed at discovering therapeutics against select first-in-class targets, with an initial focus in oncology and inflammation.

Key Contact
Name
Diego Miralles
Title
CEO
Funding Events

Date
Amount
Type
Investors
Valuation
04/30/19 $82,000,000 Series B Alexandria Venture Investments
Altitude Life Science Ventures
ARCH Venture Partners
BVF Partners
Cardinal Partners
Casdin Capital
Celgene Corporation
Mirae Asset Venture Investment
Mubadala Ventures
Nextech Invest
Trinitas Capital
Versant Ventures
undisclosed
02/24/21 $135,000,000 Series C Acuta Capital Partners
Avoro Capital Advisors
BlackRock
Boxer Capital
BVF Partners
Driehaus Capital Management
Logos Capital
RA Capital Management
SoftBank Investment Advisers
Surveyor Capital
T. Rowe Price Associates
Woodline Partners
undisclosed


Featured Reading